COVID-19 Diagnostics Market Growth Trends: An Extensive Analysis
The ongoing battle against the mutated variants of the novel coronavirus, SARS-CoV-2, has entered a new phase of challenges. Despite the initiation of vaccination programs across the globe, the world continues to grapple with an acute spike in COVID-19 cases, with populous nations like India and Brazil still facing significant containment challenges. Healthcare systems worldwide are under immense strain as the virus spreads with greater potency.
Rising Demand for COVID-19 Diagnostic Tools
COVID-19 diagnostics have played a pivotal role since the beginning of the pandemic, with the World Health Organization (WHO) emphasizing the importance of testing. The demand for molecular diagnostic tests in North America and Europe saw a staggering 20-fold increase between March and September 2020.
On April 23, 2021, the global 7-day average of COVID-19 cases reached approximately 0.8 million, marking the highest point since the pandemic began. With around 148 million confirmed cases and over 3.13 million deaths as of April 2021, the need for COVID-19 screening kits remains high, even with mass vaccination efforts in progress.
Challenges and Opportunities in the Market
The absence of a definitive treatment regimen for COVID-19 has added to the healthcare industry’s challenges. Thus far, the most effective strategies involve ramping up testing and curtailing community spread through isolation centers. However, a key impediment facing the COVID-19 diagnostics market is the lack of adequate training for medical professionals in handling testing kits.
The US Food and Drug Administration (FDA) has granted clearance for nearly 189 different diagnostic tests for SARS-CoV-2, but more efforts are required to mitigate the global pandemic. In April 2021, the FDA reissued Emergency Use Authorization (EUA) for LabCorp’s COVID-19 RT-PCR Test, allowing for at-home collection using the Pixel by LabCorp COVID-19 home collection kit.
Technological Advancements and Government Support
Research institutions are actively working on innovative point-of-care (POC) solutions for COVID-19 diagnosis, including efforts like the All-in-one dual assay based on CRISPR-Cas12a (AIOD-CRISPR) by the University of Connecticut Health Center. Integration of advanced technologies such as Artificial Intelligence (AI) and Machine Learning into testing methods is also underway.
Strong healthcare investments from public and private entities are expected to drive the development of COVID-19 diagnostics, creating new market opportunities. With a growing global population and limited prospects for a specific treatment, diagnostics will continue to be of paramount importance.
Asia Pacific’s Growing Market
Europe and North America are leading in terms of testing and spending, with the US conducting over 409.41 million tests by April 2021. In Asia Pacific, countries like India and China are aggressively pursuing testing, with India significantly expanding its testing capabilities.
Key Players in the COVID-19 Diagnostics Market
Notable players in the COVID-19 diagnostics market include Thermo Fisher Scientific, Roche Diagnostics, Abbott Laboratories, BioRAD, bioMérieux SA, and many others. These companies have reported substantial growth in sales related to COVID-19 products, reflecting the market’s potential.
As the pandemic continues to challenge the world, the demand for testing remains at its peak, creating unprecedented opportunities for market players.
Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2023-2030 – By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa) https://www.fairfieldmarketresearch.com/report/covid-19-diagnostics-market
Fairfield Market Research is a UK-based market research provider. Fairfield offers a wide spectrum of
services, ranging from customized reports to consulting solutions. With a strong European footprint, Fairfield operates globally and helps businesses navigate through business cycles, with quick responses and multi-pronged approaches. The company values an eye for insightful take on global matters, ably backed by a team of exceptionally experienced researchers. With a strong repository of syndicated market research reports that are continuously published & updated to ensure the ever-changing needs of customers are met with absolute promptness.
Fairfield Market Research
UK +44 (0)20 30025888
USA (Toll-free) +1 (844) 3829746
This press release first seen on Brilad